TNFRSF8 and cancer: In a mouse model, CD30 CAR-T cells carrying three kinds of CD30 lentiviral CARs exhibited efficient cytotoxic effects on PTCL xenograft tumors, indicating that CD30 CAR-T-cell immunotherapy may be promising for cancer treatment (100).